Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 1175 of 2871 -
Friday, February 13 2026 | 05:40:00 PM

Leading Independent Proxy Advisory Firm Glass Lewis Recommends WonderFi Shareholders Vote FOR the Proposed Transaction with Robinhood

Toronto, Ontario–(Newsfile Corp. – July 8, 2025) – WonderFi Technologies Inc. (TSX: WNDR) (OTCQB: WONDF) (WKN: A3C166) (“WonderFi” or the “Company“), is pleased to announce that leading independent proxy advisory firm Glass, Lewis & Co. (“Glass Lewis“) has recommended that holders of common shares (“Shares“) and brokers warrants (“Brokers Warrants“) …

Read More »

Jackpot Digital Signs Agreement with Multi-Casino Operator in Jamaica

Vancouver, British Columbia–(Newsfile Corp. – July 8, 2025) – Jackpot Digital Inc. (TSXV: JJ) (TSXV: JJ.WT.C) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) (“Jackpot Digital” or the “Company”), the leading provider of dealerless electronic poker tables to the global gaming industry, is pleased to announce that it has entered into an agreement (the …

Read More »

AISIX Solutions Inc. Announces Non-Brokered Private Placement of Units for Gross Proceeds up to $2,500,000

Vancouver, British Columbia–(Newsfile Corp. – July 8, 2025) – AISIX Solutions Inc., (TSXV: AISX) (FSE: QT7) (“AISIX” or “the Company“), an emerging global climate risk and data-analytics solutions provider, is pleased to announce a non-brokered private placement of up to 71,428,571 units of the Company (the “Units“) at a price per Unit …

Read More »

Standard Uranium Announces Mobilization of Exploration Crews to the Corvo Uranium Project, Northern Saskatchewan

Vancouver, British Columbia–(Newsfile Corp. – July 8, 2025) – Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) (“Standard Uranium” or the “Company“) is pleased to announce that 2025 exploration programs have begun on its Corvo Uranium Project (“Corvo“, or the “Project“), currently under a three-year earn-in option agreement with …

Read More »

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

The Company’s aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma (BCC) of the skin using Dissolvable Doxorubicin-containing Microneedle Arrays (D-MNA) Philadelphia, Pennsylvania–(Newsfile Corp. – July 8, 2025) – Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”) is pleased to …

Read More »

Beyond Lithium Announces LIFE Offering for up to $320,000 and Debt Settlement Agreement and Provides Projects Update

Winnipeg, Manitoba–(Newsfile Corp. – July 8, 2025) – Beyond Lithium Inc. (CSE: BY) (OTCQB: BYDMF) (the “Company” or “Beyond Lithium“) is pleased to announce: (i) a proposed non-brokered private placement of up to 8,000,000 units of the Company (the “Units“) at a price of $0.04 per Unit for aggregate gross proceeds of …

Read More »

Golden Spike Commences 2025 Exploration Program at Gregory River

Vancouver, British Columbia–(Newsfile Corp. – July 8, 2025) – Golden Spike Resources Corp. (CSE: GLDS) (OTCQB: GSPRF) (FSE: L5Y) (“Golden Spike” or the “Company”) is pleased to announce the launch of its 2025 summer exploration program on its 100%-owned Gregory River Copper-Gold Property (“the Property”), located in western Newfoundland. Initial …

Read More »

Military Metals Identifies New Exploration Targets and Commences 2025 Exploration Activities at West Gore Antimony Project

Vancouver, British Columbia–(Newsfile Corp. – July 8, 2025) – Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (“The Company” or “MILI”), a company focused on antimony, is pleased to announce new exploration targets at the Company’s 100% owned West Gore Antimony Project (“West Gore”, “West Gore Project”, or the …

Read More »